CALLABLE MULTI DEFENDER VONTI - JOHNSON & JOHNSON/AMGEN/MERCK & CO./PFIZER INC CALLABLE MULTI DEFENDER VONTI - JOHNSON & JOHNSON/AMGEN/MERCK & CO./PFIZER INC Stock
Certificat
RMBVTV
CH1308709075
| Real-time Bid/Ask 06:56:24 2024-05-13 EDT | ||
| 99.1 USD / 99.91 USD | -0.50% |
|
| Current month | +2.26% | ||
| 1 month | +2.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 100 | -0.19% | 0 |
| 24-05-08 | 100.2 | -0.21% | 0 |
| 24-05-06 | 100.4 | -0.09% | 0 |
| 24-05-03 | 100.5 | +1.21% | 0 |
Delayed Quote Swiss Exchange
Last update May 10, 2024 at 11:20 am
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| RMBVTV | |
| ISIN | CH1308709075 |
| Date issued | 2023-12-14 |
| Strike | 282.6 $ |
| Maturity | 2025-12-15 (582 Days) |
| Parity | 0.28 : 1 |
| Emission price | 98 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.5 $ |
|---|---|
| Lowest since issue | 96.6 $ |
| Spread | 8.1 $ |
| Spread % | 0.81% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- RMBVTV Certificat